CO2 challenge results in hypothalamic-pituitary-adrenal activation in healthy volunteers

Journal of Psychopharmacology - Tập 19 Số 3 - Trang 243-247 - 2005
Marlies A. van Duinen1, Koen Schruers, Michaël Maes, Eric Griez1
1Maastricht University, Department of Psychiatry and Neuropsychology and Vijverdal Academic Anxiety Centre, The Netherlands

Tóm tắt

The 35% CO2 challenge is known to induce symptoms of a panic attack both in panic disorder (PD) patients and healthy volunteers. Although the challenge applies more to PD patients, studies in healthy volunteers provide the opportunity to isolate the physical symptoms from thedisorder and to focus on the direct effect from the challenge on stress responsive systems. One of the main stress responsive systems is the hypothalamic-pituitary-adrenal (HPA) axis. It remains unclear whether panic symptoms are accompanied by HPA axis activation. Differences in design have hampered any comparison between studies. For example, both serum and salivary cortisol have been used to provide an index of HPA axis activation. Furthermore, indications for central HPA axisdisturbance have been suggested. The current study aimed to study the HPA axis response following the induction of panic symptoms in healthy volunteers, both at the pituitary level and at the adrenal level. Furthermore, both serum and salivary cortisol levels were determined. Subjective feelings of anxiety and, correspondingly, cortisol and ACTH levels, were found to be significantly increased following the 35% CO2 challenge. Cortisol and ACTH responses to CO2 were also associated. A significant cortisol increase was observed in both serum and salivasamples, although these were more pronounced when considering the free fraction serum values. We conclude that the induction of panic symptoms results in HPA axis activation, both at the pituitary and adrenal level. The question remains as to whether positive responders to the 35% CO2 inhalation (more specifically PD patients) show a morepronounced HPA axis response.

Từ khóa


Tài liệu tham khảo

10.1016/S0306-4530(01)00075-0

10.1176/appi.ajp.157.3.454

10.1016/0022-3956(94)00045-S

10.1016/0306-4530(87)90061-8

10.1007/s001270050163

10.1016/0165-1781(90)90121-K

10.1016/S0006-3223(03)00465-7

10.1016/0006-3223(88)90111-4

10.1111/j.0953-8194.2004.01158.x

10.1016/S0022-3956(97)00034-4

10.1159/000119004

10.1002/(SICI)1520-6394(1998)8:1<1::AID-DA1>3.0.CO;2-G

Liebowitz M R, 1985, II. Biochemical and physiological findings. Arch Gen Psychiatry, 42, 709

10.1016/S0165-1781(02)00014-8

10.1016/0165-1781(94)90085-X

10.1016/S0006-3223(98)00053-5

10.1046/j.1365-2265.1998.00549.x

Sheehan D, 1994, MINI International Neuropsychiatric Interview

10.1016/S0165-1781(99)00029-3

10.1176/ajp.151.3.408

10.1016/S0893-133X(99)00115-3

10.1016/j.pnpbp.2003.10.005

10.1002/0470846437.ch18

10.1001/archpsyc.1988.01800250051007

10.1001/archpsyc.1987.01800160077010

10.1016/S0893-133X(01)00266-4

Thông tin
Thông tin xuất bản

Journal of Psychopharmacology

Tập 19 Số 3

243-247

Thông tin tác giả